Novo Nordisk
NVO
#113
Rank
HK$1.341 T
Marketcap
HK$304.44
Share price
-1.59%
Change (1 day)
-17.75%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report